PGY-6 Chief Cardiology Fellow @HeartPlano | Methodist Dallas IM | @TCOM_UNTHSC | Interests: Advanced HF & Transplant, Cardiogenic Shock, MCS
Joined December 2019
- Tweets2.5K
- Following1.2K
- Followers979
- Likes14.4K
Pinned Tweet
Out with the old and in with the new. Excited for the next 3 years of Cardiology Fellowship! A lot of growth and learning ahead
*insert motivational David Goggins quote*
Please share any/all tips on how to survive fellowship! #MedTwitter
It’s a final match! I am blessed to have matched Advanced Heart Failure & Transplant at @NMCardioVasc @WeAreNUHeart. This is could not have been possible without the endless support and guidance from my mentors, colleagues, family, and wife. Excited for a 🥶 year!
2
2
41
What a milestone! Board certified in Adult Echocardiography 🥳 thankful for the amazing echo and imaging attendings at @HeartPlano. @ASE360 @NBE_96 #ACCFIT
10
192
What a milestone! Board certified in Adult Echocardiography! Thankful to the echo and imaging attendings at @HeartPlano for the years of teaching. @ASE360
2
93
Honored to be apart of the first CardioMems placement in Texas for @AbbottNews TEAM HF trial! This is a testament to all of the collaboration, team work, and innovation at @bswhealth_DFW @HeartPlano. @aasim_afzal @akashrusia @Cytokine_Storm @marikaharada @kalazizimd @mszerlip
💥Calling all Cardiogenic Shock enthusiasts💥 Can’t wait for this incredible event! Lots of great talks lined up. #DallasShock
🔥 Dallas Shock Symposium is just 4 days away! 🔥Don't miss out on the most anticipated discussion on cardiogenic shock—featuring world-renowned experts in the field! 🩺💥
📅 Mark your calendar!
📍 Register now ⬇️
dallasshocksymposium.com/
@HFSA @TheFACET_ @afzal_aasim @michaelhvu
3
162
One of the most exciting sessions featured in @Dallasshock2025 is “Creativity When It Matters - Unique Challenges to Shock” featuring not only restrictive and myocarditis etiologies and structural/valvular, EP, IC considerations. Free for fellows!!
Dallas shock symposium is less than a month away👍🏻⚡️Join the hottest discussion on cardiogenic shock management 💥Free registration for fellows! link➡️ facetcast.org/event/Dallas-S…
#dallasshock2025
@afzal_aasim @shelleyhallmd @Babar_Basir @RyanTedfordMD @bswhealth_DFW @michaelhvu
2
191
What a great paper to start JCF intersections!
The inaugural article in @JCFINT takes a fresh look at the intersection of EP + HF through the lens of AFFIRM
📌 56% of AF patients had HFpEF
⚠️ Rhythm control with Class Ic/sotalol ↑ mortality in HFpEF
✅ Amiodarone showed safer profile
🔗 onlinejcfi.org/article/S3050…
#CardioX
170
@Dallasshock2025 is a can’t-miss day! Register online and get the chance to learn from an incredible line-up.
Don’t miss the inaugural Dallas Shock Symposium, led by an all-star duo—Dr. Timothy George and Dr. Aasim Afzal. Seats are limited, so register now to secure your spot!
👉 More info & registration: facetcast.org/event/Dallas-S…
1
10
Can’t miss opportunity to talk about all things shock! Consider registering to learn more about contemporary management of shock
Dallas Shock Symposium 2025💥 on 8/23/25 !! Don’t miss the opportunity to join the world renowned experts’ discussions on cardiogenic shock, MCS strategies and more!! Register now!!➡️facetcast.org/event/Dallas-S…
@Dallasshock2025 @bswhealth_DFW
129
#DallasShock2025 exciting line-up of experts to talk all things about Cardiogenic Shock! I can’t wait for the line-up on system based care of CS and utilization of a multi-disciplinary shock team. Register below! facetcast.org/event/Dallas-S…
1
1
110
Speechless! I am honored to win the Cardiology Fellow of the Year award. This is not possible without the teaching and camaraderie at @HeartPlano. Blessed to have attendings, co-fellows, and other staff members that teach us. 🔥 going into my chief year and applying for AHFTx!
The ASE invited @ZuyueWangMD to present a focused webinar on Tricuspid Regurgitation Repair and Replacement. Dr. Wang is a leader in structural echocardiography and a dedicated educator at @HeartPlano. Never miss a chance to learn from her!
2
265
Join The Heart Hospital - Plano and FSR on 2/27/25 at 4pm CST for FSR Sarcoidosis Journal Club! We will be discussing the PRESTIGE TRIAL (doi.org/10.1016/j.jcmg.2023.…). Looking forward to this opportunity and the discussion! Register at the link below.
us02web.zoom.us/meeting/regi…
Happy to share that I’ll be presenting abstracts at #ACC2025 and #ISHLT 2025! Can’t wait to see everyone there, network, and talk HF and Cardiogenic Shock 😁 @HeartPlano
1
14
297
All star clinical pearls for #echofirst in HCM, MR, and LVOT obstruction 🌟
I make this point for every single #HCM talk. We wrote about this at @ACCinTouch.org
In patients with HCM , MR and LVOT Signal on #Echofirst can be quite confusing.
In addition to double checking the SBP with MR jet to confirm LVOT gradient/following tricks can be useful
➡️MR signal velocity is always higher because it gives the LV-to-LA gradient
• LVOT signal velocity is lower
➡️ HOCM MR envelope is wider, begins after the onset of ejection, and terminates at the end of IVR
•LVOT signal is narrower and spans the ejection time
➡️ HOCM MR envelope Curved initially but then straightens out (perpendicular to baseline) by midsystole
•LVOT signal is classic late peaking, dagger shaped, and continues to show rightward curvature in mid-late systole
Differentiating the HOCM MR Signal From Other Causes of MR
➡️Most other MR signals (except mitral valve [MV] prolapse) have onset at the isovolumetric contraction (IVC) phase and last until isovolumetric relaxation (IVR; i.e., pansystolic MR).
➡️ HOCM MR begins after IVC during the ejection phase but persists until IVR. This gives the HOCM MR signal its characteristic initial curved appearance, which is different from most other MR signals.
🔗 acc.org/Education-and-Meetin…
221
The trial that I’m most excited about to come out of #TCT2024. Exciting news for intermediate risk PE’s!
#SimPub #CircTCT24 PEERLESS Randomized Control Trial: in patients with acute intermediate-risk pulmonary embolism (PE), large-bore mechanical thrombectomy (LBMT) significantly reduced adverse outcomes, comparted with catheter-directed thrombolysis (CDT)
ahajrnls.org/3UuyGvP
2
186
I spy our very own @kalazizimd! Whether you’re going into IC or not, it’s crucial that we all more than familiar with what goes on in the cath lab. ACS and STEMI are some of the most exciting parts of cardiology @HeartPlano
